Tag: Northwestern

PAE

US IDE trial finds embolization “safe and efficacious” for benign prostatic...

A prospective US FDA-approved investigational device exemption (IDE) study has demonstrated significant improvement in lower urinary tract symptoms secondary to benign prostatic hyperplasia and...

Northwestern University adopts radioembolization with TheraSphere as first-line treatment for HCC

BTG has announced that following positive results of its 15-year experience between 2003 and 2017 with TheraSphere, Northwestern University, Illinois, USA, has adopted Y-90...